WHO ICTRP trial
A DOUBLE-BLIND, RANDOMISED, PARALLEL-GROUP STUDY TO COMPARE THE SAFETY AND…
EUCTR2010-019343-20-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019343-20-HU |
|---|---|
| Public title | A DOUBLE-BLIND, RANDOMISED, PARALLEL-GROUP STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO DOSE LEVELS OF OMS210 WITH PLACEBO IN THE TREATMENT OF PATIENTS WITH DIARRHOEA PREDOMINANT IRRITABLE BOWEL SYNDROME |
| Scientific title | A DOUBLE-BLIND, RANDOMISED, PARALLEL-GROUP STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO DOSE LEVELS OF OMS210 WITH PLACEBO IN THE TREATMENT OF PATIENTS WITH DIARRHOEA PREDOMINANT IRRITABLE BOWEL SYNDROME |
| Primary sponsor | LOTUS PHARMACEUTICAL CO., LTD. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;United Kingdom;Germany;Czech Republic;Belgium |
| Conditions | Diarrhoea predominant irritable bowel syndrome MedDRA version: 12.1 Level: LLT Classification code 10048571 Term: Irritable bowel syndrome aggravated |
| Interventions | Product Name: OMS210 Pharmaceutical Form: Capsule* INN or Proposed INN: 5-Chloro-2-(1,4-diazacycloheptan-1-y1)-7-methylbenzoxazole CAS Number: 270917-08-3 Current Sponsor code: OMS210 Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Apr 26, 2010 |
| Target size | 417 |
| Secondary IDs | 654-002 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: